Improved Intraocular Lens Delivery System Released

Article

The enhanced system gives eye care professionals the ability to safely deliver an intraocular lens through incisions as small as 2.2 mm.

Bausch + Lomb today released an enhanced intraocular lens (IOL) loading system, giving eye care professionals the ability to safely deliver its IOL through unenlarged phaco incisions as small as 2.2 mm.

First introduced in February 2014, the BLIS injector system includes a reusable titanium hand piece to deliver the enVista hydrophobic acrylic IOL. Now, the enhanced BLIS system features a softened plunger tip that is 2 mm longer than the older model, allowing for easier placement in the capsular bag.

“As a surgeon who has implanted a substantial number of enVista IOLs using BLIS, it was great to work seamlessly with Bausch and Lomb to further enhance and develop the next-generation BLIS injector system,” said Anil Shivaram, an eye care professional, in a press release. “With the upgraded features in BLIS, I look forward to using this enhanced system with the enVista IOL.”

The enVista IOL is designed to provide long-term eyesight clarity to patients and reduce posterior capsular opacification, which can cause clouded vision after surgery. It is the first and only FDA-approved IOL.

Related Videos
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Image credit: motortion | stock.adobe.com - Young depressed woman talking to lady psychologist during session, mental health
Image credit:  JPC-PROD | stock.adobe.com - Choosing method of contraception : Birth control pills, an injection syringe, condom, IUD-method, on grey
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Health care provider examining MRI images of patient with multiple sclerosis -- Image credit: New Africa | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.